Severity
Low
FDA Drug recall · Reported January 24, 2018
Presence of foreign substance: metallic razor blade was found in one bottle.
Hetero Labs, Ltd. - Unit III recalled Simvastatin Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pha… - a low-severity action.
Simvastatin Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pha… was recalled by Hetero Labs, Ltd. - Unit III in January 24, 2018. Reason: Presence of foreign substance: metallic razor blade was found in one bottle.. Check the official notice for the remedy. Verify recall #D-0223-2018 with the FDA Drug before acting.
The recall
Hetero Labs, Ltd. - Unit III issued this low-severity FDA Drug recall-Presence of foreign substance: metallic razor blade was found in one bottle..
Sourced from official FDA Drug enforcement records. Verify recall #D-0223-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0223-2018) was formally reported on January 24, 2018, with the manufacturer initiating the action on December 22, 2017. It is classified under Low severity (Class III), with a current status of Terminated. Hetero Labs, Ltd. - Unit III is listed as the recalling firm, operating out of Hyderabad, N/A. Federal records list the affected scope as N/A.
The documented reason for this recall is: Presence of foreign substance: metallic razor blade was found in one bottle. Distribution data in the federal record shows the product reached: U.S.A. nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 3,731 children & baby products recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
N/A
Related Recalls
6
0 from same agency
Simvastatin Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured by: Hetero (trademark), Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-513-10
Presence of foreign substance: metallic razor blade was found in one bottle.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-0223-2018 |
| Date reported | January 24, 2018 |
| Date initiated | December 22, 2017 |
| Recalling firm | Hetero Labs, Ltd. - Unit III |
| Firm location | Hyderabad, N/A |
| Affected scope | N/A |
| Distribution | U.S.A. nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Xishentang Dongguan Trading Co, Ltd., dba Pretty-Life, of China · 2026-07-02
Diamond Wipes International, Inc. of Chino, California · 2026-07-02
· 2026-07-02
· 2026-07-02
Sanven Technology Ltd., dba Vevor, of Rancho Cucamonga, California · 2026-07-02
Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported January 24, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.